RPL regal partners limited

0.97%

$3.05

Opthea dead in the water, page-5

First 5 Last

Share
Profile

Follow
cutty

3,828 Posts.

497

24/03/25

11:34

Post #: 78387641
Share

Originally posted by Esmer: ↑

Did some some research into OPT at the weekend, and also into RPL's apparent 30% holding in OPT. A hazy horror story has emerged.

It turns out that the recent big fall in RPL's SP is probably because RPL holds 30% of OPT, and OPT has recently fallen by nearly 50%. OPT this morning announced much anticipated phase 3 results that were so bad that OPT may become insolvent. OPT's shares have been suspended for the last week and remain suspended. Although it can be suspected that OPT's recent SP fall may have been caused by insider trading ahead of the terrible results announcement, there is no need to suspect any insider trading as being a cause of RPL's recent SP fall. RPL's SP fall would have been caused simply as a reaction to OPT's SP fall.

Part of RPL's holding in OPT appears to not actually be at the risk of RPL. Some of RPL's OPT holding is held by RPL on behalf of RF1 for whom RPL acts as an investment manager. So, some of the recent big fall in RPL's 30% holding in OPT will have been at the expense of RF1's NTA rather than at RPL's expense. A holding in OPT is mentioned in RF1's monthly report for January. RF1's holding in OPT would be partly responsible for RF1's NTA falling by 20 cents recently.

In my opinion, OPT ranks as an unproven speccy pharma. Although many were predicting a bright future for OPT, speccy pharmas tend to be more risky than a visit to the casino. I am now much more cautious about RPL's prospects than I used to be, now that I know that RPL's investment strategies allow them to put so many eggs into one basketcase.

Can't really complain. There were some good swing trading opportunities on the way down, which provided an overall profit amidst the gloom. Next on the RPL agenda is picking the bottom. What could possibly go (more) wrong?

Expand

My understanding is RF1's exposure is secondary.

That is, the fund (RF1) holds a range of unlisted managed funds controlled by Regal.

Accordingly, RF1's exposure is due to their holdings in Regal Emerging Companies fund. Not from a direct holding in OPT.

All the same, nonetheless.

As for the recent sell down - and dumping by the CEO - never a good look.

RPL Price at posting: $2.53 Sentiment: None Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

ETM

As Trump-Greenland hype dies off, Energy Transition buys a niobium project in Spain

TMG

Trigg moves into US defence-heavy tungsten space with market reaction mixed

Oz will likely unveil commodity price supports, but don't expect Trumpian flare

NEU

Neuren Pharma jumps on DAYBUE sales win; short sellers' report now history

MQR

'We're extremely encouraged': Marquee expands footprint at Mt Clement

Thursday's HotCopper trends: $266M LTR placement, Trigg expansion | Aug 7

LTR

Liontown locks in $266M placement to help cashflow, Kathleen Valley ramp-up

ASX Market Close: Health Care stocks lead index lower | August 7, 2025

XRG

The market just found its latest defence play: XReality up +45% on Texas contract

LIN

Lindian jumps 8pc after being awarded full costs as Deep Blue Sea case thrown out

First 5 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $3.05		Change -0.030(0.97%)		Mkt cap ! $1.033B

Open	High	Low	Value	Volume
$3.03	$3.08	$3.02	$1.049M	344.4K

Buyers (Bids)

No.	Vol.	Price($)
1	10000	$3.04

Sellers (Offers)

Price($)	Vol.	No.
$3.08	12794	2

View Market Depth

No.	Vol.	Price($)
1	10000	3.040
3	9762	3.020
4	10944	3.000
2	10802	2.990
1	3300	2.970

Price($)	Vol.	No.
3.080	12794	2
3.100	100	1
3.120	4000	1
3.130	6000	1
3.150	16138	4

Last trade - 16.10pm 08/08/2025 (20 minute delay)

RPL (ASX) Chart

Opthea dead in the water, page-5

As Trump-Greenland hype dies off, Energy Transition buys a niobium project in Spain

Trigg moves into US defence-heavy tungsten space with market reaction mixed

Oz will likely unveil commodity price supports, but don't expect Trumpian flare

Neuren Pharma jumps on DAYBUE sales win; short sellers' report now history

'We're extremely encouraged': Marquee expands footprint at Mt Clement

Thursday's HotCopper trends: $266M LTR placement, Trigg expansion | Aug 7

Liontown locks in $266M placement to help cashflow, Kathleen Valley ramp-up

ASX Market Close: Health Care stocks lead index lower | August 7, 2025

The market just found its latest defence play: XReality up +45% on Texas contract

Lindian jumps 8pc after being awarded full costs as Deep Blue Sea case thrown out

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Opthea dead in the water, page-5

Top Stories

As Trump-Greenland hype dies off, Energy Transition buys a niobium project in Spain

Trigg moves into US defence-heavy tungsten space with market reaction mixed

Oz will likely unveil commodity price supports, but don't expect Trumpian flare

Neuren Pharma jumps on DAYBUE sales win; short sellers' report now history

'We're extremely encouraged': Marquee expands footprint at Mt Clement

Thursday's HotCopper trends: $266M LTR placement, Trigg expansion | Aug 7

Liontown locks in $266M placement to help cashflow, Kathleen Valley ramp-up

ASX Market Close: Health Care stocks lead index lower | August 7, 2025

The market just found its latest defence play: XReality up +45% on Texas contract

Lindian jumps 8pc after being awarded full costs as Deep Blue Sea case thrown out

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News